BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34831335)

  • 1. Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis.
    Moser T; Hoepner L; Schwenker K; Seiberl M; Feige J; Akgün K; Haschke-Becher E; Ziemssen T; Sellner J
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
    Moser T; Schwenker K; Seiberl M; Feige J; Akgün K; Haschke-Becher E; Ziemssen T; Sellner J
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2199-2212. PubMed ID: 33002321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
    Sellner J; Koczi W; Harrer A; Oppermann K; Obregon-Castrillo E; Pilz G; Wipfler P; Afazel S; Haschke-Becher E; Trinka E; Kraus J
    Clin Exp Immunol; 2013 Sep; 173(3):381-9. PubMed ID: 23611040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
    Mitosek-Szewczyk K; Tabarkiewicz J; Wilczynska B; Lobejko K; Berbecki J; Nastaj M; Dworzanska E; Kolodziejczyk B; Stelmasiak Z; Rolinski J
    J Neurol Sci; 2013 Sep; 332(1-2):35-40. PubMed ID: 23835090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis.
    Paź A; Fiszer U; Zaborski J; Korlak J; Członkowski A; Członkowska A
    Eur J Neurol; 1999 May; 6(3):347-52. PubMed ID: 10210917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly.
    De Martinis M; Modesti M; Loreto MF; Quaglino D; Ginaldi L
    Life Sci; 2000 Dec; 68(2):139-51. PubMed ID: 11191633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis.
    Comi G; Cook S; Giovannoni G; Rieckmann P; Sørensen PS; Vermersch P; Galazka A; Nolting A; Hicking C; Dangond F
    Mult Scler Relat Disord; 2019 Apr; 29():168-174. PubMed ID: 30885375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy.
    Wiendl H; Schmierer K; Hodgkinson S; Derfuss T; Chan A; Sellebjerg F; Achiron A; Montalban X; Prat A; De Stefano N; Barkhof F; Leocani L; Vermersch P; Chudecka A; Mwape C; Holmberg KH; Boschert U; Roy S;
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36411081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
    Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
    Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological consequences of "immune reconstitution therapy" in multiple sclerosis: A systematic review.
    Sellner J; Rommer PS
    Autoimmun Rev; 2020 Apr; 19(4):102492. PubMed ID: 32062028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review.
    Deftereos SN; Vavougios GD; Bakirtzis C; Hadjigeorgiou G; Grigoriadis N
    Curr Pharm Des; 2024; 30(7):536-551. PubMed ID: 38343058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation.
    Shimizu Y; van Seventer GA; Horgan KJ; Shaw S
    Immunol Rev; 1990 Apr; 114():109-43. PubMed ID: 2196219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory Effects Associated with Cladribine Treatment.
    Fissolo N; Calvo-Barreiro L; Eixarch H; Boschert U; Espejo C; Montalban X; Comabella M
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
    Harrer A; Pilz G; Wipfler P; Oppermann K; Sellner J; Hitzl W; Haschke-Becher E; Afazel S; Rispens T; van der Kleij D; Trinka E; Kraus J
    Clin Exp Immunol; 2015 Jun; 180(3):383-92. PubMed ID: 25603898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.
    Mao Z; Álvarez-González C; Allen-Philbey K; De Trane S; Yildiz O; Campion T; Adams A; Turner BP; Marta M; Gnanapavan S; Espasandin M; Mathews J; Giovannoni G; Baker D; Schmierer K
    Mult Scler Relat Disord; 2019 Jan; 27():247-253. PubMed ID: 30419510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
    Kopadze T; Döbert M; Leussink VI; Dehmel T; Kieseier BC
    Eur J Neurol; 2009 Mar; 16(3):409-12. PubMed ID: 19175384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine.
    Holm Hansen R; von Essen MR; Reith Mahler M; Cobanovic S; Sellebjerg F
    Front Immunol; 2024; 15():1327672. PubMed ID: 38433828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjögren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 1995; 15(3-4):235-53. PubMed ID: 8834450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.